Topics
Diagnosis, Epidemiology
Modality
Biomarker / Liquid biopsy, Imaging
Study type
Not listed
Abstract
Circulating tumor cells (CTC) provide a minimally invasive window into metastatic disease but are difficult to detect and estimate due to their rarity and heterogeneity. Conventional enrichment-based approaches introduce selection bias and fail to capture diverse CTC populations. Single-cell RNA sequencing (scRNA seq) enables…
Authors
Shivam Kumar, Divya Janjua, Udit Joshi, Tanya Tripathi +5
AI-generated summary
Direct detection of rare circulating tumor cells in peripheral blood mononuclear cells by scRNA seq: Spike-in strategy based feasibility study. reports: Circulating tumor cells (CTC) provide a minimally invasive window into metastatic disease but are difficult to detect and estimate due to their rarity and heterogeneity. Conventional enrichment-based approaches introduce selection bias and fail to capture diverse CTC populations. Single-cell RNA sequencing (scRNA seq) enables unbiased transcriptomic profiling of diverse cell types and rare population within complex samples like blood.
This summary may be inaccurate. Verify with the primary paper.
Primary source: PubMed.